I read a lot medhost.com.pl AdvaMed, a trade group representing medical-device makers, said it has long supported the concept of an identifier system for high-risk devices but said it would likely be a “costly and challenging endeavor” that needs to be done right the first time. St. Jude declined to comment, and Medtronic said it still was evaluating the FDA’s final rule.